  |
| Submit a Manuscript | Editorial Board | Author Instructions | Article Alerts |
Dear Colleague,
We are delighted to welcome Dr Eugene Chin (Shanghai Institute of Biological Sciences) and Dr Domenico Coppola (Moffitt Cancer Centre) as the new Editors-in-Chief of Cancer Cell International. They bring with them a wealth of expertise and will assist our esteemed Editorial Board in providing a rapid and fair peer-review service.
We would also like to share some of our recently published, highly accessed articles with you.
| Read our highly accessed articles |
 | Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp KO Alfarouk et al. 15:71 (15 July 2015) |
 | Only one health, and so many omics N Pećina-Šlaus, M Pećina 15:64 (23 June 2015) |
 | Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma J Li et al. 15:48 (2 May 2015) |
 | B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway F Kang et al. 15:45 (21 April 2015) |
| About Cancer Cell International |
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from work using cell culture techniques.
Much of cancer work relates to biological experiments in which cells are grown in vitro, in two- or three-dimensional systems. Such experiments have provided crucial data in many fields, from the chemoattraction of immune cells or blood vessel endothelial cells (angiogenesis), to measurements of effective doses of drugs, irradiation and other modalities. Cancer Cell International considers manuscripts that include animal work (in vivo) only if the work is a logical progression from previous work in vitro.
| Reasons to publish with Cancer Cell International |
 | High quality peer-review service |
| Rapid publication following acceptance |
| No space constraints nor limits on the number of color figures, movies or additional files |
Keep up to date – get the latest articles delivered straight to your inbox.
Best wishes,
The Cancer Cell International Editorial Team
 Follow BioMed Central:      For further information or enquiries please contact Customer Services at: info@biomedcentral.com. | |||||||
Only one health, and so many omicsCancer Cell International 2015, 15:64 doi:10.1186/s12935-015-0212-2 The electronic version of this article is the complete one and can be found online at:http://www.cancerci.com/content/15/1/64
© 2015 Pecina-Slaus and Pecina. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. AbstractThe development of new approaches based on wide profiling methods in studying biological and medical systems is bringing large amounts of data on a daily basis. The causes of complex diseases have been directed to the genome examination bringing formidable knowledge. We can study genome, but also proteome, exome, transcriptome, epigenome, metabolome, and newcomers too such as microbiome, connectome and exposome. The title of this editorial is paraphrasing the famous saying of Victor Schlichter from Buenos Aires children hospital in Argentina who said “How unfair! Only one health, and so many diseases”. Today there is indeed a whole lot of omics. We think that we are lucky to have all the omics possible, but we also wanted to stress the importance of future holistic approach in integrating the knowledge omics has rewarded us. Keywords:Omics; Genomics; Proteomics; Epigenomics; Metabolomics; Microbiomics; Cancer |
No hay comentarios:
Publicar un comentario